News and Updates

The American Diabetes Association’s Scientific Sessions is here! Until June 16, scientists will present some of the most updated topics, from beta cell replacement to regeneration and glucose and complications trials, all with the result to change things for the type 1 diabetes (T1D) community. Here are Drs. Martin de Bock, Brigitte Frohnert, Matthias Hebrok […]

Expert advice from a Licensed Professional Counselor who also lives with T1D.

Scientists have uncovered a potential breakthrough in developing a faster acting insulin in an unusual place: snails. Now, Breakthrough T1D-funded researchers are using the molecular features of the snail insulin to create ultra-rapid insulins for people with type 1 diabetes (T1D) and have published their findings in . As discussed in last year’s blog, certain […]

At Breakthrough T1D, we are committed to funding the development of new therapies to keep people with type 1 diabetes (T1D) healthier, longer, until cures are found. We saw an incredible number of key advances that have both improved the lives of those living with the disease today and that have taken us so much […]

A historical account about a past initiative that would help pave the way for Breakthrough T1D’s future approach to identifying research priorities.

Becky Lois, Ph.D., discussed how parents can help children cope with the psychosocial challenges of living with T1D during quarantine.

Details about the TrialNet study, including why Hydroxychloroquine, and the status of subject participation.

ViaCyte, a regenerative medicine company long-supported by Breakthrough T1D, today announced $27 million in financing to continue the development of beta cell therapies for diabetes. This funding ensures that Viacyte’s innovative approaches to replacing the insulin-producing beta cells in people with type 1 diabetes (T1D) will keep progressing. “Beta cell therapies are a key component […]

Breakthrough T1D welcomes the May 26th announcement by the Centers for Medicare & Medicaid Services about more affordable insulin options for people in the Medicare program.

Virtual Visits Can Transform Care and Improve Outcomes for People with T1D